Pharma major Pfizer on Friday said it has decided to withdraw its application for Emergency Use Authorisation (EUA) of its COVID-19 vaccine in India. Pfizer was the first pharmaceutical firm …
authorisation
-
-
US President Joe Biden a week after inauguration has undone another marker of Donald Trump’s presidency. The new administration has withdrawn a rule that rescinded work authorisation for spouses of …
-
Health Secretary Rajesh Bhushan said on Tuesday that the Ministry was prepared to roll out the vaccine for COVID-19 within 10 days of emergency use authorisation clearance and subject to …
- News
Coronavirus live updates | ‘COVID-19 vaccine rollout within 10 days from emergency use authorisation date’
The budget session of Parliament is expected to be held under similar COVID-19 safety measures and restrictions, including strict physical distancing norms, that were in place for the monsoon session. …
- News
India’s SEC to decide on approving Serum Institute of India’s Covishield vaccine for emergency use authorisation
India’s Central Drugs Standard Control Organisation’s Subject Expert Committee(SEC) is set to hold a meeting today to decide on approving the Covishield vaccine developed by Serum Institute of India (SII) …
- News
Grant Emergency Authorisation to Covid Vaccines Only After Enough Trials: Parl Committee Warns Govt
On the eve of India getting it’s first COVID-19 vaccine, Parliamentary Standing Committee on Home Affairs has warned the government against rushing through authorisation. The Anand Sharma-led committee, in its …
-
The FDA approval is a bright light in a needlessly dark time, says President-elect Joe Biden A U.S. government advisory panel has recommended emergency approval for the Pfizer-BioNTech coronavirus vaccine, …
- News
What Will Decide Grant of Emergency Use Authorisation For Vaccine? Here Are Possible Scenarios for 3 Candidates
New Delhi: The Subject Expert Committee set up by the CDSCO, the Drugs Controller General of India, will on Wednesday afternoon examine the data submitted by three companies studying the …
- News
Bharat Biotech seeks emergency use authorisation for Indian Covid-19 vaccine; expert panel to review
The Hyderabad-based pharmaceutical firm Bharat Biotech applied to the Drugs Controller General of India (DCGI) on Monday for granting emergency use authorisation for its COVID-19 vaccine Covaxin, becoming the third …
- News
Bharat Biotech seeks emergency use authorisation for Covaxin days after Pfizer and SII – India News , Firstpost
Last week, Prime Minister Narendra Modi had said that a COVID-19 vaccine ‘may be ready in a few weeks’ at an all-party meeting COVAXIN vaccine by Bharath Biotech. New Delhi: After …
-
The Serum Institute of India (SII) on December 6 applied to the Drugs Controller General of India (DCGI) to seek emergency use authorisation for its COVID-19 vaccine candidate Covishield. It is …
- News
Pfizer seeks emergency use authorisation of its COVID-19 vaccine in India – Health News , Firstpost
In its application to the Drugs Controller General of India, Pfizer has sought permission to import the vaccine for sale and distribution in India, as per official sources Representational Image. …
-
After its parent company secured such clearance in the UK and Bahrain, Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India (DCGI) …
- News
SII to seek emergency use authorisation for AstraZeneca COVID-19 vaccine in 2 weeks: Adar Poonawalla
The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks. Adar Poonawalla, Founder and CEO, SII said on Saturday …
- General
US FDA grants emergency use authorisation to Regeneron antibody therapy given to Donald Trump – Health News , Firstpost
The green light for drugmaker Regeneron came after REGEN-COV2, was shown to reduce COVID-19-related hospitalizations or emergency room visits in patients with underlying conditions A sign for the Food And …